Dear Friends and Colleagues,

We are delighted to invite you to the 52nd Annual Meeting of the EBMT, taking place in Madrid, Spain, from 22 to 25 March 2026.

For over six decades, Haematopoeitic Cell Transplantation (HCT) has been the foundation of cellular therapy for malignant and non-malignant diseases, bridging experimental biology and clinical practice. This has paved the way for genetically modified Immune Effector Cells and Gene Therapy, further revolutionising the field. The EBMT plays a pivotal role in fostering interdisciplinary collaboration, advancing scientific research, and expanding clinical applications. Our Annual Meeting highlights the latest breakthroughs, reinforcing our commitment to excellence. We particularly encourage young scientists to contribute to the basic science content, ensuring continued innovation in the field.

The EBMT 2026 in Madrid offers a unique opportunity to connect with experts and engage in the latest scientific developments. It is a key event for professionals in transplantation and cellular therapy, featuring specialised sessions for Physicians, Nurses, Data Managers, Statisticians, Quality Managers, Cell Therapists, Paediatricians, Pharmacists, Psychologists, Transplant Coordinators, Lab Scientists, Trainees, as well as Patients, Family Members and Donors.

Madrid is a vibrant and welcoming city, known for its rich cultural heritage and dynamic contemporary scene. As one of Europe’s leading cultural destinations, it provides the perfect backdrop for an inspiring and engaging meeting.

We look forward to welcoming you to Madrid in March 2026 for an exceptional scientific and professional experience.